ATE422199T1 - 4- (aryl)(aryloxy)methyl piperidinderivate und ihre verwendung als serotonin und/oder noradrenalin reuptake inhibitoren - Google Patents

4- (aryl)(aryloxy)methyl piperidinderivate und ihre verwendung als serotonin und/oder noradrenalin reuptake inhibitoren

Info

Publication number
ATE422199T1
ATE422199T1 AT99500208T AT99500208T ATE422199T1 AT E422199 T1 ATE422199 T1 AT E422199T1 AT 99500208 T AT99500208 T AT 99500208T AT 99500208 T AT99500208 T AT 99500208T AT E422199 T1 ATE422199 T1 AT E422199T1
Authority
AT
Austria
Prior art keywords
serotonin
aryloxy
aryl
reuptake inhibitors
methyl piperidine
Prior art date
Application number
AT99500208T
Other languages
English (en)
Inventor
Venero Aurelio Orjales
Avello Antonio Toledo
Duran Carmen Pumar
Original Assignee
Faes Fabrica Espanola De Produ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Fabrica Espanola De Produ filed Critical Faes Fabrica Espanola De Produ
Application granted granted Critical
Publication of ATE422199T1 publication Critical patent/ATE422199T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99500208T 1998-11-18 1999-11-10 4- (aryl)(aryloxy)methyl piperidinderivate und ihre verwendung als serotonin und/oder noradrenalin reuptake inhibitoren ATE422199T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802420A ES2157148B1 (es) 1998-11-18 1998-11-18 Nuevas piperidinas 4-sustituidas.

Publications (1)

Publication Number Publication Date
ATE422199T1 true ATE422199T1 (de) 2009-02-15

Family

ID=8305832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99500208T ATE422199T1 (de) 1998-11-18 1999-11-10 4- (aryl)(aryloxy)methyl piperidinderivate und ihre verwendung als serotonin und/oder noradrenalin reuptake inhibitoren

Country Status (21)

Country Link
EP (1) EP1002794B1 (de)
JP (1) JP4667552B2 (de)
KR (1) KR100646675B1 (de)
AR (1) AR028805A1 (de)
AT (1) ATE422199T1 (de)
AU (1) AU757177B2 (de)
BR (1) BR9905634B1 (de)
CA (1) CA2288533C (de)
CY (1) CY1108955T1 (de)
CZ (1) CZ296053B6 (de)
DE (1) DE69940378D1 (de)
DK (1) DK1002794T3 (de)
ES (2) ES2157148B1 (de)
HR (1) HRP990354B1 (de)
HU (1) HU227558B1 (de)
IL (1) IL132862A0 (de)
NO (1) NO314401B1 (de)
PL (1) PL196329B1 (de)
PT (1) PT1002794E (de)
RU (1) RU2232753C2 (de)
TR (1) TR199902839A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003227519A1 (en) * 2002-05-30 2003-12-19 Head Explorer A/S The use of milnacipran for the treatment of tension-type headache
UA77536C2 (en) * 2002-07-03 2006-12-15 Lundbeck & Co As H Secondary aminoaniline piperidines as mch1 antagonists and their use
KR20050071647A (ko) * 2002-11-01 2005-07-07 뉴로서치 에이/에스 신규한 피페리딘 유도체 및 모노아민 신경전달물질 재흡수억제제로서의 이의 용도
WO2005092885A1 (en) * 2004-02-27 2005-10-06 Eli Lilly And Company 4-amino-piperidine derivatives as monoamine uptake inhibitors
AU2005265093A1 (en) 2004-06-18 2006-01-26 Wyeth Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
EP1854785A1 (de) * 2006-05-12 2007-11-14 Faes Farma, S.A. 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulponat: Anwendungen, Verfahren zur Synthese und pharmazeutische Zusammensetzungen
WO2008023258A1 (en) * 2006-08-23 2008-02-28 Pfizer Products Inc. Piperidine derivatives
NZ592543A (en) * 2008-11-14 2013-02-22 Theravance Inc 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
JP2012524098A (ja) * 2009-04-15 2012-10-11 セラヴァンス， インコーポレーテッド ３−（フェノキシピロリジン−３−イル−メチル）ヘテロアリール、３−（フェニルピロリジン−３−イルメトキシ）ヘテロアリールおよび３−（ヘテロアリールピロリジン−３−イルメトキシ）ヘテロアリール化合物
EP2390248A1 (de) 2010-05-24 2011-11-30 Faes Farma, S.A. Flufenoxinderivate zur Behandlung und Vorbeugung von Amiloydpathologien
MA34327B1 (fr) 2010-05-24 2013-06-01 Faes Farma S A A Spanish Corp Dérivés de flufénoxine pour le traitement et la prévention des pathologies amyloïdes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1203149A (en) * 1968-06-10 1970-08-26 Ici Ltd Piperidine derivatives
JPH0615529B2 (ja) * 1985-04-01 1994-03-02 エーザイ株式会社 新規ピペリジン誘導体
JPH0840999A (ja) * 1994-08-04 1996-02-13 Yamanouchi Pharmaceut Co Ltd フルオロインダン誘導体
AUPN037195A0 (en) * 1995-01-03 1995-01-27 Australian Nuclear Science & Technology Organisation Piperidine-based sigma receptor ligands
CO5150201A1 (es) * 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina

Also Published As

Publication number Publication date
TR199902839A3 (tr) 2000-09-21
EP1002794A1 (de) 2000-05-24
KR20000035525A (ko) 2000-06-26
ES2323742T3 (es) 2009-07-23
CA2288533C (en) 2009-01-06
NO314401B1 (no) 2003-03-17
CA2288533A1 (en) 2000-05-18
DK1002794T3 (da) 2009-04-14
HUP9904086A2 (hu) 2000-11-28
HRP990354A2 (en) 2000-06-30
CY1108955T1 (el) 2014-07-02
KR100646675B1 (ko) 2006-11-17
ES2157148B1 (es) 2002-03-01
JP4667552B2 (ja) 2011-04-13
IL132862A0 (en) 2001-03-19
BR9905634B1 (pt) 2012-09-04
BR9905634A (pt) 2000-09-26
AU757177B2 (en) 2003-02-06
AR028805A1 (es) 2003-05-28
DE69940378D1 (de) 2009-03-19
JP2000154176A (ja) 2000-06-06
HRP990354B1 (en) 2008-11-30
NO995643D0 (no) 1999-11-17
CZ296053B6 (cs) 2005-12-14
HUP9904086A3 (en) 2001-11-28
RU2232753C2 (ru) 2004-07-20
NO995643L (no) 2000-05-19
ES2157148A1 (es) 2001-08-01
HU227558B1 (en) 2011-08-29
PT1002794E (pt) 2009-03-25
HU9904086D0 (en) 2000-01-28
CZ399599A3 (cs) 2000-08-16
PL336607A1 (en) 2000-05-22
PL196329B1 (pl) 2007-12-31
TR199902839A2 (xx) 2000-09-21
AU5936699A (en) 2000-05-25
EP1002794B1 (de) 2009-02-04

Similar Documents

Publication Publication Date Title
ATE302193T1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
DE60336251D1 (de) Identifikation von aufzeichnungsmedien
DE59905858D1 (de) Verwendung von pit-emulsionen
ATE460398T1 (de) Verwendung von omega-carboxyaryl-substituierten diphenylharnstoffen als raf-kinase-inhibitoren
DE60312659D1 (de) Leichtgewicht identifizierung von informationen
NO20012339D0 (no) Nye piperazin- og piperidinforbindelser
DE60030574D1 (de) Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren
FR2843963B1 (fr) Nouvelles molecules derivees de la noraporphine
ATE329906T1 (de) Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren
DE60044061D1 (de) Sicherung von datenübertagungen
ATE398107T1 (de) N-pyrrolidin-3-yl-amide-derivate als inhibitoren der serotonin- und noradrenalin-wiederaufnahme
ATE422199T1 (de) 4- (aryl)(aryloxy)methyl piperidinderivate und ihre verwendung als serotonin und/oder noradrenalin reuptake inhibitoren
NO984380L (no) Nye piperazin og piperidinforbindelser
DE50313157D1 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
ATE384054T1 (de) Substituierte benzoxazinones und ihre verwendung
DE60101386D1 (de) Piperazin- und piperidinverbindungen
DE60310461D1 (de) Elektrofotografisches Aufzeichnungsblatt und Aufzeichnungsverfahren
ATE499096T1 (de) Kombination von serotonin-wiederaufnahme-hemmern und agomelatin
ATE553097T1 (de) Piperidin- und piperazin-substituierte n- hydroxyformamiden zur verwendung als metalloproteinaseinhibitoren
FR2758327B1 (fr) Nouvelles arylpiperazines derivees de piperidine
DE60322052D1 (de) N-acylaminoacetonitril-derivate und ihre verwendung zur kontrolle von parasiten
DE50004274D1 (de) Substituierte 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one und ihre verwendung als lipase-hemmer
ATE390413T1 (de) 4-(2-phenylsulfanyl-phenyl)-1,2,3,6- tetrahydropyridinderivaten zur verwendung als serotonin-wiederaufnahmehemmer
DE50006852D1 (de) Verwendung von nanoskaligen deodorantien
ATE254102T1 (de) Derivate von heterocycloalkylbenzocyclobutan und heteroarylbenzocyclobutan und deren verwendung als inhibitoren der wiederaufnahme von serotonin und noradrenalin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1002794

Country of ref document: EP

EEFA Change of the company name